KZIANasdaqManufacturing

Kazia Therapeutics Ltd (KZIA) earnings date, market-implied expected move, and options open interest by expiry

8.54

Closed16:00 ET

Open8.72Volume230,437Mkt cap$688.0MEPS-0.02

Day8.19 – 9.0640%52-wk4.86 – 17.4029%

KZIA

Kazia Therapeutics Ltd

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

52dKazia (KZIA) Raises Approximately $40M in Gross Proceeds and Expands Paxalisib. Is the Capital Base Stronger than the Clinical Evidence?

News

Next report

Last report

—

Largest filed tie

—

Largest filed tie

13F top-10 QoQ

+57.17%

shares held · 10 largest managers

13F · Jun 30 '26123d lag

35 managers

Top fund weight

—

No upcoming report date for Kazia Therapeutics (KZIA). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

OI · 2 expiries · Oct 21 close

0.05OI · 2 expiries · Oct 21 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

65+7%Nov 2020d1,426+2%

140%Feb 19111d0.02598+1%0.02

ExpiryPutsCallsP/C

Nov 2020d65+7%1,426+2%0.05

Feb 19111d140%598+1%0.02

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

GDP ×1.08· ±6.3% vs ±5.8% · 20 releases

eventrelease day|move|up · n×base

GDPgross domestic product±6.3%8 of 20×1.08

PCEpersonal income & outlays±4.9%11 of 20×0.84

PPIproducer prices±4.9%5 of 11×0.83

FOMCrate decision±4.8%8 of 25×0.82

CPIconsumer prices±4.6%4 of 11×0.78

CPROFcorporate profits±4.2%3 of 12×0.73

NFPjobs report±4.1%5 of 10×0.70

Bar = avg |move| to ±7% · tick = ±5.8% avg day · ×base = |move| ÷ ±5.8% · min 6 releases

Earnings history

No reported quarters.

Methodology

ties · implied moves · holdersMethod